Brent M. Hunter - 08 Jul 2022 Form 4 Insider Report for Codex DNA, Inc. (TBIO)

Role: Vice President, Finance & PFO
Signature: /s/ Rob Cutler, as Attorney-in-Fact
Issuer symbol: TBIO
Transactions as of: 08 Jul 2022
Net transactions value: $0
Form type: 4
Filing time: 11 Jul 2022, 19:47:22 UTC
Previous filing: 01 Mar 2022
Next filing: 08 Aug 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TBIO	Stock Option (right to buy)	Award	$0	+51,300		$0.000000	51,300	08 Jul 2022	Common Stock	51,300	$2.07	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan) through each applicable vesting date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest in equal monthly installments on the same day of the month as the Vesting Commencement Date. "Vesting Commencement Date" shall mean June 6, 2022.

Content

Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan) through each applicable vesting date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest in equal monthly installments on the same day of the month as the Vesting Commencement Date. "Vesting Commencement Date" shall mean June 6, 2022.